levamisole has been researched along with Schizophrenia in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (80.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lin, DY | 1 |
Ivanova, SA; Logvinovich, GV; Vasi'leva, OA; Vetlugina, TP | 1 |
Abramova, LI; Koliaskina, GI; Mikheeva, TV; Sekirina, TP; Tsutsul'kovskaia, MIa | 1 |
Koliaskina, GI; Mikheeva, TV; Orlova, VA; Sekirina, TP; Tsutsul'kovskaia, MIa | 1 |
AvrutskiÄ, GIa; Golodets, RG; Maksutova, EL; Mogilina, NP; Semenov, SF | 1 |
1 trial(s) available for levamisole and Schizophrenia
Article | Year |
---|---|
[Use of the immunomodulator levamisole in the complex treatment of juvenile schizophrenics with an unfavorable course].
Topics: Adult; Antipsychotic Agents; Clinical Trials as Topic; Double-Blind Method; Drug Resistance; Humans; Leukocyte Count; Levamisole; Male; Middle Aged; Schizophrenia; T-Lymphocytes; T-Lymphocytes, Regulatory | 1987 |
4 other study(ies) available for levamisole and Schizophrenia
Article | Year |
---|---|
Cox regression analysis of multivariate failure time data: the marginal approach.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bias; Clinical Trials as Topic; Cluster Analysis; Colonic Neoplasms; Diabetic Retinopathy; Female; Fluorouracil; Humans; Infections; Levamisole; Longitudinal Studies; Male; Markov Chains; Monte Carlo Method; Multivariate Analysis; Prognosis; Proportional Hazards Models; Recurrence; Schizophrenia; Software | 1994 |
[Phagocytosis of immune complexes by leukocytes in patients with schizophrenia].
Topics: Adjuvants, Immunologic; Adult; Antigen-Antibody Complex; Culture Media; Female; Humans; In Vitro Techniques; Leukocytes; Levamisole; Male; Middle Aged; Phagocytosis; Schizophrenia | 1989 |
[Use of levamisole in the combined therapy of patients with slowly progressing juvenile schizophrenia].
Topics: Adolescent; Adult; Chronic Disease; Drug Evaluation; Drug Therapy, Combination; Humans; Leukocyte Count; Levamisole; Male; Psychotropic Drugs; Schizophrenia; T-Lymphocytes; T-Lymphocytes, Regulatory | 1988 |
[Clinico-immunological aspects of using levamisole in psychiatric practice].
Topics: Adjuvants, Immunologic; Adult; Aged; Antibody Formation; Chronic Disease; Drug Evaluation; Drug Resistance; Drug Therapy, Combination; Female; Humans; Immunity, Cellular; Levamisole; Male; Middle Aged; Neurocognitive Disorders; Psychotropic Drugs; Schizophrenia | 1988 |